Global Growth Stocks With High Insider Ownership July 2026
In July 2026, global markets are navigating a complex landscape marked by declining inflation rates and mixed performances across major indices, with large-cap tech stocks experiencing notable setbacks. Amidst these fluctuations, growth companies with high insider ownership can offer unique insights into potential resilience and alignment of interests between management and shareholders.
Top 10 Growth Companies With High Insider Ownership Globally
| Name | Insider Ownership | Earnings Growth |
| Zhejiang Taotao Vehicles (SZSE:301345) | 27.9% | 31.5% |
| Suzhou Dongshan Precision Manufacturing (SZSE:002384) | 33.5% | 73.1% |
| Shanghai Biren Technology (SEHK:6082) | 11% | 116.9% |
| Meitu (SEHK:1357) | 22.8% | 31.2% |
| Meiko Electronics (TSE:6787) | 19.2% | 28.0% |
| KebNi (OM:KEBNI B) | 11.8% | 90.9% |
| Guangzhou Tinci Materials Technology (SZSE:002709) | 38.4% | 28.9% |
| Gold Circuit Electronics (TWSE:2368) | 30.1% | 38.2% |
| CD Projekt (WSE:CDR) | 35.2% | 29.7% |
| Biocytogen Pharmaceuticals (Beijing) (SEHK:2315) | 14.1% | 40.4% |
Let's uncover some gems from our specialized screener.
Gpixel Changchun Microelectronics (SEHK:3277)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Gpixel Changchun Microelectronics Inc. designs and supplies customized and off-the-shelf CMOS image sensor solutions, with a market cap of HK$32.20 billion.
Operations: The company's revenue segment includes CN¥856.51 million from semiconductors.
Insider Ownership: 18.2%
Earnings Growth Forecast: 36.3% p.a.
Gpixel Changchun Microelectronics is experiencing robust growth, with earnings forecasted to rise significantly over the next three years. Recent guidance indicates a substantial revenue increase of 75% to 80% and profit growth of up to 210% for the first half of 2026, driven by demand in industrial imaging applications. Despite high volatility and lower future return on equity expectations, the stock trades below its estimated fair value, indicating potential investment appeal amid strong insider ownership dynamics.
- Delve into the full analysis future growth report here for a deeper understanding of Gpixel Changchun Microelectronics.
- Upon reviewing our latest valuation report, Gpixel Changchun Microelectronics' share price might be too optimistic.
Jiangsu HSC New Energy MaterialsLTD (SHSE:688353)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Jiangsu HSC New Energy Materials Co., LTD., along with its subsidiaries, focuses on the research, development, production, and sale of electrolyte additives for lithium-ion batteries both in China and internationally, with a market capitalization of approximately CN¥13.82 billion.
Operations: The company generates revenue primarily from its Specialty Chemicals segment, amounting to CN¥1.03 billion.
Insider Ownership: 17.8%
Earnings Growth Forecast: 87.2% p.a.
Jiangsu HSC New Energy Materials is experiencing rapid growth, with earnings expected to rise significantly, outpacing the broader Chinese market. The company recently reported a strong turnaround in profitability, with net income reaching CNY 97.02 million for Q1 2026 compared to a loss last year. Despite high share price volatility and non-cash earnings concerns, the stock trades well below its estimated fair value and benefits from substantial insider ownership.
- Click here and access our complete growth analysis report to understand the dynamics of Jiangsu HSC New Energy MaterialsLTD.
- Our valuation report here indicates Jiangsu HSC New Energy MaterialsLTD may be undervalued.
BrainsWay (TASE:BWAY)
Simply Wall St Growth Rating: ★★★★★☆
Overview: BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally, with a market cap of ₪2.01 billion.
Operations: The company's revenue segment includes the development and commercialization of its Deep TMS System, generating $56.22 million.
Insider Ownership: 12.2%
Earnings Growth Forecast: 32.5% p.a.
BrainsWay is experiencing robust growth, with earnings forecasted to rise significantly, outpacing the Israeli market. Recent data highlights the efficacy of its Deep TMS technology for treating PTSD and MDD, although FDA clearance for these indications is pending. Q1 2026 saw a strong financial performance with sales reaching US$15.53 million and net income doubling from last year. The company anticipates continued revenue growth of up to 30% this year amidst positive cash flow projections.
- Unlock comprehensive insights into our analysis of BrainsWay stock in this growth report.
- Our valuation report unveils the possibility BrainsWay's shares may be trading at a premium.
Make It Happen
- Click this link to deep-dive into the 715 companies within our Fast Growing Global Companies With High Insider Ownership screener.
- Seeking Other Investments? Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com